Today Custodix is recognized as one of the most advanced and reliable Trusted Service Providers (TSPs) in the Healthcare sector providing both consultancy and technical privacy protection solutions. Its data protection services are supported by a combination of high-level technical and legal expertise in privacy protection and e-security and a sound experience with a number of advanced e-security solutions such as PKI, VPN, Web Services security frameworks, time-stamping and more.

Custodix helps businesses deal with all security and privacy related aspects of modern data management (cf. European Data Protection Directive 95/46/EC, 2001/20/EC, 2005/28/EC, the US HIPAA Privacy Rule, the WHO GCP, GPMP/ICH/135/95, ...) by offering end-to-end solutions for data protection in e-Clinical Trials, disease management and other longitudinal studies. Custodix has an international customer-base, deploying services in Europe, Asia and Australia. Customers are both commercial companies and governmental research organizations.

In its short existence, Custodix has already been involved in several e-privacy and e-security IST projects (FP5, FP6) and other funded research projects (e.g. support from the Flemish government), including the EU flagship project: ACGT (Advanced Clinico-Genomic Trials on Cancer, developing a Biomedical GRID infrastructure for sharing clinical and genomic expertise, 2006-2010). Custodix' commitment to European research for the future has already been consolidated in the new FP7-programme through its major role in the TAS3 (Trusted Architecture for Securely Shared Services) project (Kick-off Q1 2008).